{"id":"W4200384155","doi":"10.1093/ofid/ofab466.701","title":"502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab","year":2021,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"William Osler Health System","funders":"","keywords":"Medicine; Placebo; Clinical endpoint; Internal medicine; Interim analysis; Coronavirus disease 2019 (COVID-19); Randomization; Clinical trial; Relative risk; Disease; Confidence interval; Pathology; Infectious disease (medical specialty)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000121251,0.000450013,0.000717085,0.0002331407,0.0005647729,0.0006267322,0.000320923,0.0001261674,0.00009336982],"category_scores_gemma":[0.0002302496,0.000354812,0.00030174,0.0007700303,0.0002075379,0.000509128,0.0003432423,0.0002240124,0.0002810655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008058876,"about_ca_system_score_gemma":0.003177517,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006745797,"about_ca_topic_score_gemma":0.001664467,"domain_scores_codex":[0.9971476,0.0001617529,0.0003529637,0.0008816888,0.0005537641,0.0009021899],"domain_scores_gemma":[0.9982329,0.0001780874,0.0001233976,0.0009134636,0.0002672815,0.0002848774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00130361,0.002477051,0.9382527,0.000201572,0.0006668368,0.0033538,0.0002714137,0.000004061566,0.04569983,0.001216135,0.002684171,0.003868771],"study_design_scores_gemma":[0.02571809,0.008635841,0.06131116,0.0003524637,0.001315916,0.001595794,0.0009029424,0.0001456408,0.2152248,0.001764158,0.6817558,0.001277307],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9643295,0.0009888145,0.0003341935,0.002099458,0.0001628267,0.001574702,0.000127702,0.0003177957,0.03006504],"genre_scores_gemma":[0.9306757,0.00004913064,0.00007120678,0.06826548,0.0001226843,0.0003199022,0.0001073188,0.000090941,0.0002976597],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8769416,"threshold_uncertainty_score":0.9998904,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04781342582594231,"score_gpt":0.3907940115901449,"score_spread":0.3429805857642025,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}